CardioComm Solutions Issues Shares for Services and Debt
Toronto, Ontario--(Newsfile Corp. - July 2, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces shares and options.Under an online marketing and awareness program agreement with AGORA Internet Relations Corp. ("AGORACOM") the Company has issued to AGORACOM 188,333 common shares of the Company ("Shares"), representing a price of $0.06 per Share,...
2019-07-02 8:32 AM EDT
CardioComm Solutions to Issue Shares for Services and Debt
Toronto, Ontario--(Newsfile Corp. - June 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) (OTC PINK: EKGGF) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its third issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press...
2019-06-10 11:15 PM EDT
CardioComm Solutions Announces ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC
Toronto, Ontario--(Newsfile Corp. - May 15, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces the execution of an ECG and multiple biosign monitoring device integration and co-marketing agreement with California-based BodiMetrics LLC ("BodiMetrics"). With the launch of CardioComm's GEMS™ Universal ECG app ("GEMS™ Universal"),...
2019-05-15 9:20 AM EDT
CardioComm Solutions GEMS(TM) Universal ECG App Launched in Partnership with Multiple ECG Device Manufacturers
Toronto, Ontario--(Newsfile Corp. - May 14, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announced today that its GEMS™ Universal ECG app ("GEMS™ Universal"), a version of the Company's US Food and Drug Administration ("FDA") cleared and Health Canada approved GEMS™ Mobile ECG app, is now available for download from the Google Play...
2019-05-14 8:51 AM EDT
CardioComm Solutions' Heartcheck(TM) CardiBeat Handheld ECG Device Cleared by Health Canada for Direct-to-Consumer Sales
Toronto, Ontario--(Newsfile Corp. - May 9, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received approval from Health Canada for the over-the-counter ("OTC") sales and marketing of its existing GEMS™ Mobile smartphone app and for the HeartCheck™ CardiBeat, its newest handheld heart rhythm monitor. Both devices were cleared by the...
2019-05-09 8:37 AM EDT
CardioComm Solutions Provides Financing Update
Toronto, Ontario--(Newsfile Corp. - April 12, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, confirms that it has repaid $100,000 in outstanding loans and that the remaining $500,000 in loans, which would have otherwise matured on March 31, 2019, have been extended by the lenders.The maturing loans were made by four lenders to the Company in...
2019-04-12 8:44 AM EDT
CardioComm Solutions Files with Health Canada for Direct to Consumer Sales Approval of the Heartcheck(TM) Cardibeat Handheld ECG Device
Toronto, Ontario--(Newsfile Corp. - April 9, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has filed with Health Canada for approval for the over-the-counter ("OTC") sales and marketing of their GEMS™ Mobile smartphone app and their newest handheld, heart rhythm monitor, the HeartCheck™ CardiBeat. Both were cleared by the Food and Drug...
2019-04-09 8:29 AM EDT
CardioComm Solutions to Issue Shares Under Online Marketing and Awareness Program
Toronto, Ontario--(Newsfile Corp. - April 6, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it has made its second issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company initially announced the online marketing and awareness program in its press releases dated...
2019-04-06 4:58 PM EDT
CardioComm Solutions to Issue Shares Under Online Marketing and Awareness Program
Toronto, Ontario--(Newsfile Corp. - April 2, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announced that it will make its second issuance of shares under its online marketing and awareness program with AGORA Internet Relations Corp. ("AGORACOM"). The Company previously announced the online marketing and awareness program in press releases dated...
2019-04-02 6:44 PM EDT
CardioComm Solutions Issues Stock Options
Toronto, Ontario--(Newsfile Corp. - April 1, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, issued 125,000 stock options to Etienne Grima, the Company's CEO, in accordance with his employment agreement. The options are exercisable at $0.05 per share for five years from the date of grant and vest immediately. The grants are subject...
2019-04-01 3:00 PM EDT
CardioComm Solutions Launches New GEM(TM) Mobile Universal ECG App Expanding ECG Reporting Services Across Global Markets
Toronto, Ontario--(Newsfile Corp. - March 25, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, announces the release of a new version of the Company's recently cleared US Food and Drug Administration ("FDA") GEMS™ Mobile ECG app. The new version is branded as the GEMS™ Universal ECG ("GEMS™ Universal") and is capable of connecting...
2019-03-25 8:33 AM EDT
CardioComm Solutions Leverages the GEMS(TM) Mobile ECG App to Bring a Third FDA Cleared HeartCheck(TM) Branded ECG Device to the US Consumer Markets
Toronto, Ontario--(Newsfile Corp. - March 21, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms the start of an OEM co-marketing agreement for the HeartCheck™ Palm handheld ECG device, the Company's newest GEMS™ Mobile ECG app ("GEMSTM Mobile") enabled ECG device. The HeartCheck™ Palm will be the Company's third US Food and...
2019-03-21 8:30 AM EDT
CardioComm Solutions Releases Remote 12-lead ECG Telemed Solution with Arrythmia Detection and ECG Reading Services
Toronto, Ontario--(Newsfile Corp. - March 14, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has released GlobalCardio 12 FLEX ("GC12 FLEX"), a complete remote 12- lead ECG acquisition and reading solution. GC12 FLEX has been developed for use by clinics and telemedicine groups that operate from multiple locations and that require rapid and...
2019-03-14 8:23 AM EDT
CardioComm Solutions Prepares New FDA Applications for Direct-to-Consumer and Physician Use Cardiac Arrhythmia Algorhythms
Toronto, Ontario--(Newsfile Corp. - March 5, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, is preparing US Food and Drug Administration ("FDA") 510(k) Class II medical device clearance applications for new arrhythmia detection algorithms.The main application will be for GEMS™ Rhythm, a full suite of arrhythmia detection tools designed...
2019-03-05 8:30 AM EST
Innovation Continues as the FDA Clears CardioComm Solutions' Novel ECG Smartphone App and Heartcheck(TM) Device for Direct to Consumer Sales
Toronto, Ontario--(Newsfile Corp. - February 25, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received approval from the US Food and Drug Administration ("FDA") for the over-the-counter ("OTC") sales and marketing of their device agnostic GEMS™ Mobile smartphone app and their newest handheld, heart rhythm monitor, the...
2019-02-25 8:28 AM EST
CardioComm Solutions Engages US Law Firm to Address Licensing and IP Opportunities
Toronto, Ontario--(Newsfile Corp. - February 21, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has retained Whiteford, Taylor & Preston L.L.P. to assist in software licensing and intellectual property business matters on a go forward basis.Whiteford, Taylor & Preston includes over 170 attorneys in sixteen offices...
2019-02-21 8:09 AM EST
CardioComm Solutions Now Offers a Smartphone Connected FDA Cleared 12 Lead ECG Belt Under a New Co-Marketing Agreement
Toronto, Ontario--(Newsfile Corp. - February 13, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has entered into a device technology relationship for the co-marketing and US sales of a Smartphone connected 12 lead ECG wearable device. The announcement follows the successful integration and testing of the device with...
2019-02-13 8:21 AM EST
CardioComm Solutions' HeartCheck(TM) Device Enters Final FDA Review Phase
Toronto, Ontario--(Newsfile Corp. - January 29, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms it has completed a request for additional information from the US Food and Drug Administration ("FDA") for the Company's premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat...
2019-01-29 8:55 AM EST
CardioComm Solutions Completes Work on Arrhythmia Detection Algorithms with Artificial Intelligence-Based Learning
Toronto, Ontario--(Newsfile Corp. - January 10, 2019) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms completion of a six month collaborative project with researchers at the University of Victoria, Canada, leading the way to a release of artificial intelligence ("AI") enhancements to CardioComm's Global ECG Management Solution...
2019-01-10 9:00 AM EST
CardioComm Solutions' HeartCheck CardiBeat FDA 510(k) Review Extended
Toronto, Ontario--(Newsfile Corp. - December 31, 2018) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, confirms the USA Food and Drug Administration ("FDA") has reduced the scope of their request for additional information for the Company's premarket notification 510(k), Class II medical device clearance application for the HeartCheck™...
2018-12-31 5:00 PM EST